SkinDermic
Company

SkinDermic

Biotechnology Research Paris, Fr 5 employees
Employees
5

SkinDermic Overview

Headquarters
Paris, Fr
Website
skindermic.com
Industry
Biotechnology Research
Employees
5
Founded
2017
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About SkinDermic

SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris.

SkinDermic Contact Details

People in AeroLeads
2

SkinDermic Org Chart

Sample employees and titles
Name Title Contact
Vincent Calvez Professor of Medicine, Head
View
Nicolas Dupin Past-président De La Société Française
View

Compare Similar Companies to SkinDermic